Alston & Bird LLP advised OncoSec Medical Incorporated on the deal. OncoSec Medical Incorporated, a late-stage biotechnology company, has closed a public offering of common stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
